
CiVi Biopharma
CiVi Biopharma: A US-based biotech firm specializing in R&D for cardiovascular and metabolic diseases.
- 14
- Public
Founded with a mission to innovate in the biopharmaceutical sector, CiVi Biopharma is a clinical-stage biotechnology company based in the United States. The company focuses on research and development of novel oral antisense oligonucleotide therapies targeting cardiovascular and metabolic diseases. By leveraging cutting-edge science, CiVi Biopharma aims to address significant unmet medical needs in these critical areas.
CiVi Biopharma's leadership includes experienced professionals from the biotech and pharmaceutical industries, contributing to its strategic direction and scientific advancements. The company has garnered attention for its promising pipeline, including key projects like CiVi 030 and CiVi 008. Through its innovative approach and dedicated R&D efforts, CiVi Biopharma is making a substantial impact on the treatment landscape for cardiovascular and metabolic conditions.
Similar Companies

Rivus Pharmaceuticals
rivuspharma.com

Riparian Pharmaceuticals

Cardurion Pharmaceuticals
cardurion.com

Cargene
cargene.com
BioCardia
Algorithm Sciences

Omniox
omniox.com
Nativis
nativis.com

Acesis BioMed
acesisbio.com

Covanos
covanos.com

OrsoBio
orsobio.com

Bond Biosciences
bond.bio
Receptor Life Sciences
receptorlife.com
Elex Biotech

Cogent Biosciences
cogentbio.com
Quick Facts
Who are CiVi Biopharma's competitors?
Companies similar to CiVi Biopharma include Rivus Pharmaceuticals, Riparian Pharmaceuticals, Cardurion Pharmaceuticals and Cargene.
When was CiVi Biopharma founded?
CiVi Biopharma was founded in 2016.
Where is CiVi Biopharma's headquarters located?
CiVi Biopharma's headquarters is located in Chevy Chase, MD, US.
When was CiVi Biopharma's last funding round?
CiVi Biopharma's most recent funding round was for $49M (USD) in May 2018.
How much disclosed funding has CiVi Biopharma raised?
As of May 22, 2018, CiVi Biopharma has disclosed funding of $89M (USD). Undisclosed round amounts are excluded.
How many employees does CiVi Biopharma have?
CiVi Biopharma has 14 employees as of Feb 4, 2024.
Classification
- Customer
- Main Product
- NAICS
- 540000Professional, Scientific, and Technical Services
- 541714Research and Development in Biotechnology (except Nanobiotechnology)
- 541000Professional, Scientific, and Technical Services
- 541700Scientific Research and Development Services
- 541710Research and Development in the Physical, Engineering, and Life Sciences
- SIC
- 8700Engineering, Accounting, Research, Management, And Related Services
- 8730Research, Development, And Testing Services
- 8731Commercial Physical and Biological Research
Show 13 more industry codes
- NAICS
- 320000Manufacturing
- 325400Pharmaceutical and Medicine Manufacturing
- 620000Health Care and Social Assistance
- 325000Chemical Manufacturing
- 623000Nursing and Residential Care Facilities
- 325410Pharmaceutical and Medicine Manufacturing
- 325412Pharmaceutical Preparation Manufacturing
- SIC
- 2800Chemicals And Allied Products
- 8000Health Services
- 2830Drugs
- 8040Offices And Clinics Of Other Health Practitioners
- 2834Pharmaceutical Preparations
- 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified